antimicrobial resistance
Keeping tabs on pharma: UK hails “major step forward” in treating schizophrenia
February 08 by Leila HawkinsUK approves first long-acting new treatment for schizophrenia, Venus Remedies joins coalition to tackle anti-microbial resistance (AMR) and FDA resumes medical device inspections as Covid rates drop
Keeping tabs on pharma: Novo Nordisk’s diabetes "game-changer" and the rise of antibiotic resistance
January 21 by Leila HawkinsIn Pharma IQ’s latest news bulletin: Novo Nordisk India’s ground-breaking diabetes pill, the threat of antibiotic resistance and a new nasal drug that could combat Covid-19
Rethinking the Way we Fight Bacteria
May 07 by Pharmaceuticals & Biotechnology EditorNew research-based pharmaceutical industry report provides insights on how to slow down antimicrobial resistance (AMR) and boost antibiotic R&D R&D pharmaceutical companies are currently w...
Antibiotics – do you think they’re a cure for the common cold?
November 18 by Pharma IQ NewsAn Ipsos MORI poll commissioned by the Royal Society of Chemistry has shown that 74% of the public believe that a major research and development effort is needed to create new antibiotics for fighting...
Antimicrobial Drug Development – The Past, the Present, and the Future
March 10 by Pharmaceuticals & Biotechnology EditorAntimicrobial resistance has been an issue since the introduction into clinical use of the first agents in the 1940s. Although the discovery and development of new classes of antimicrobials through th...